Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization

Tuberculosis (TB) is an infectious disease resulting in millions of deaths annually worldwide. TB treatment is challenging due to a huge number of global latent infections and due to multidrug-resistant forms of TB. Inhaled administration of anti-TB drugs using dry powder inhalers has various advant...

Descripción completa

Detalles Bibliográficos
Autores principales: Eedara, Basanth Babu, Fan, Claire, Sinha, Shubhra, Khadka, Prakash, Das, Shyamal C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536221/
https://www.ncbi.nlm.nih.gov/pubmed/37765321
http://dx.doi.org/10.3390/pharmaceutics15092354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536221/
https://www.ncbi.nlm.nih.gov/pubmed/37765321
http://dx.doi.org/10.3390/pharmaceutics15092354

Ejemplares similares